DK1035856T3 - Isoleret DNA kodende for human H3-histaminreceptor - Google Patents

Isoleret DNA kodende for human H3-histaminreceptor

Info

Publication number
DK1035856T3
DK1035856T3 DK98953282T DK98953282T DK1035856T3 DK 1035856 T3 DK1035856 T3 DK 1035856T3 DK 98953282 T DK98953282 T DK 98953282T DK 98953282 T DK98953282 T DK 98953282T DK 1035856 T3 DK1035856 T3 DK 1035856T3
Authority
DK
Denmark
Prior art keywords
dna encoding
encoding human
isolated dna
histamine receptor
histamine
Prior art date
Application number
DK98953282T
Other languages
English (en)
Inventor
Mark Erlander
Arne Huvar
Timothy W Lovenberg
Jayashree Pyati
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1035856T3 publication Critical patent/DK1035856T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
DK98953282T 1998-10-07 1998-10-07 Isoleret DNA kodende for human H3-histaminreceptor DK1035856T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/021090 WO2000020011A1 (en) 1998-10-07 1998-10-07 Isolated dna encoding human h3 histamine receptor

Publications (1)

Publication Number Publication Date
DK1035856T3 true DK1035856T3 (da) 2007-04-23

Family

ID=22268042

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98953282T DK1035856T3 (da) 1998-10-07 1998-10-07 Isoleret DNA kodende for human H3-histaminreceptor

Country Status (9)

Country Link
EP (1) EP1035856B1 (da)
JP (1) JP4231627B2 (da)
AU (1) AU757749B2 (da)
CA (1) CA2312274C (da)
DE (1) DE69836873T2 (da)
DK (1) DK1035856T3 (da)
ES (1) ES2279584T3 (da)
HK (1) HK1028566A1 (da)
WO (1) WO2000020011A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2316283A1 (en) * 1997-12-26 1999-07-08 Banyu Pharmaceutical Co., Ltd. Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein
JP2000189171A (ja) 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
GB9924941D0 (en) 1999-10-22 1999-12-22 Univ Manchester Treatment of dyskinesia
WO2002064212A1 (en) 2001-02-13 2002-08-22 Cornell Research Foundation, Inc. Method and compositions for reducing cardiac dysfunctions with a selective histamine h3 receptor agonist
WO2002092634A2 (de) * 2001-04-27 2002-11-21 Schaefer Ute Für histaminrezeptorsubklassen spezifische antikörper
US7767881B2 (en) 2001-07-02 2010-08-03 Banyu Pharmaceutical Co., Ltd. Utilization of histamine receptor h3 gene participating in body weight or food intake control
EP1463817A4 (en) * 2001-11-13 2005-07-20 Merck & Co Inc HISTAMINE RECEPTOR H3 POLYNUCLEOTIDES
WO2003091282A1 (fr) * 2002-04-24 2003-11-06 Banyu Pharmaceutical Co., Ltd. Mutant a activite ordinaire du recepteur h3 de l'histamine et utilisation correspondante

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093545A (en) * 1997-12-04 2000-07-25 Millennium Pharmaceuticals, Inc. Methods for detecting nucleic acid molecules encoding a member of the muscarinic family of receptors
CA2316283A1 (en) * 1997-12-26 1999-07-08 Banyu Pharmaceutical Co., Ltd. Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein

Also Published As

Publication number Publication date
JP4231627B2 (ja) 2009-03-04
JP2002526049A (ja) 2002-08-20
EP1035856A4 (en) 2003-03-26
AU1069299A (en) 2000-04-26
ES2279584T3 (es) 2007-08-16
HK1028566A1 (en) 2001-02-23
DE69836873T2 (de) 2007-07-05
EP1035856B1 (en) 2007-01-10
EP1035856A1 (en) 2000-09-20
DE69836873D1 (de) 2007-02-22
CA2312274C (en) 2011-07-12
WO2000020011A1 (en) 2000-04-13
CA2312274A1 (en) 2000-04-13
AU757749B2 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
NO984772L (no) Tidlig evalueringssystem med boreevne
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
DK1115721T3 (da) Pyrimidonderivater
NO20005508D0 (no) Adenosin-A3-reseptormodulatorer
NO996252L (no) Ettborings-stigerør
ATE280157T1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
DE69910462D1 (de) Cervicalorthese
ATE272632T1 (de) Muskarin-rezeptor antagonisten
DE69930175D1 (de) Kohlenwasserstoffsensor
ID24726A (id) Antagonis-antagonis reseptor trombin
DE69902440D1 (de) Rollstuhl
NO20011460D0 (no) Cytokinreseptor zalphall
DK1035856T3 (da) Isoleret DNA kodende for human H3-histaminreceptor
EP1100896A4 (en) DNA CODING FOR THE SNORF33 RECEPTOR
EP1151006A4 (en) HUMAN G PROTEIN TORQUE RECEPTOR
DE60027161D1 (de) Für das saccharose-pts-enzym ii kodierende dna
ID25990A (id) Susunan dna
EE200300335A (et) Histamiiniretseptori antagonistid
DE69930017D1 (de) Glaskeramischer körper
IT244395Y1 (it) Maniglia regolabile per carrozzine
FI980989A (fi) Ihopotentiaalianturi
DE19983520D2 (de) Behaglichkeitssensor
ES1041026Y (es) Vibrador terapeutico.
GB0128161D0 (en) Receptor protein
DE69914015D1 (de) Verbinder